Lymphoma Net - Home
Supporting people with non-Hodgkin's lymphoma
What to expect from non-Hodgkin's lymphoma


  • Patients with aggressive non-Hodgkin's lymphoma often go to their doctor with symptoms at an early stage of the disease
  • Despite the fast-growing nature of the disease, it is receptive to many forms of treatment and a cure is achieved in many cases
  • Even without a cure, many patients achieve a disease-free period, or 'remission'

Aggressive non-Hodgkin's lymphoma

Aggressive non-Hodgkin's lymphoma is one of the two main classifications of non-Hodgkin's lymphoma, the other being indolent. Aggressive non-Hodgkin's lymphomas are sometimes known as fast-growing or high-grade non-Hodgkin's lymphomas.

Natural course of the disease

Aggressive non-Hodgkin's lymphomas are sometimes known as fast-growing, or high-grade, non-Hodgkin's lymphomas.

As these names suggest, aggressive non-Hodgkin's lymphomas grow quickly. Because of this, patients are likely to notice symptoms and to go to their doctor, and so be referred for specialist treatment at a relatively early stage of the illness.

Although the name 'aggressive' sounds very frightening, these lymphomas often respond very well to treatment. Even patients whose disease does not respond well to first-line, standard treatment, often do well with high-dose chemotherapy and stem cell transplants. In fact, aggressive non-Hodgkin's lymphomas are more likely to be completely cured than indolent non-Hodgkin's lymphomas.

In order to predict how well a patient will respond to treatment, and their likelihood of experiencing a relapse, doctors often use the International Prognostic Index (IPI). This consists of a list of five factors:

  • The patient's age
  • The stage of their non-Hodgkin's lymphoma
  • Levels of the enzyme lactate dehydrogenase (LDH) in their blood, which indicates the amount of tumour in the body
  • The number of places outside the lymphatic system where tumours are found
  • The patient's overall health

Importance of treatment

Treatments are available for all types of non-Hodgkin's lymphoma. In the case of aggressive non-Hodgkin's lymphoma, a complete cure is possible in between 40% and 75% of cases. Even in those patients who are not cured, a 'remission' (disease-free period) can often be achieved.

The type of treatment used will depend on many things, including:

  • The type of the non-Hodgkin's lymphoma
  • The staging of the non-Hodgkin's lymphoma
  • Where the lymphoma is
  • The general health of the patient and their age

It is important that the patient attends follow-up appointments for check-ups and tests, even if the lymphoma has apparently been cured or a remission achieved. A significant number of aggressive non-Hodgkin's lymphomas relapse, and further treatment may be needed.

What to expect

Patients who are diagnosed with early-stage aggressive non-Hodgkin's lymphoma are usually treated with combination chemotherapy, in which more than one chemotherapy drug is given. This treatment is frequently given in combination with the monoclonal antibody rituximab.

Radiotherapy is often given as well, either after the chemotherapy or at the same time. It is directed specifically at any affected lymph nodes.

Although it is not possible to predict a patient's response, treatment of early-stage aggressive non-Hodgkin's lymphoma achieves a cure or a 'remission' (disease-free period) in 80% or more of patients.

Patients who are diagnosed with advanced-stage aggressive non-Hodgkin's lymphoma are given similar chemotherapy to early-stage patients. Radiotherapy may be given as well.

This standard treatment achieves a cure in between 40% and 70% of cases, although the patient's response to treatment will be different in every case.

In patients with non-Hodgkin's lymphoma that does not respond well to treatment, or whose disease relapses, further treatment is needed. High-dose chemotherapy may be tried and a peripheral blood stem cell transplant may be performed. This is can achieve a cure in roughly between 30% and 50% of patients.

If treatment is not successful, or is not possible, then medical management is likely to be aimed at controlling symptoms or at being palliative.

For more information on this topic, see How non-Hodgkin's lymphoma is treated.


How useful did you find the information on this page?


Legal statement